1. What happens after stopping Wegovy or Zepbound? Withdrawal trials show that substantial weight regain is common after semaglutide or tirzepatide is stopped. The evidence supports planning maintenance before treatment ends rather than assuming the goal weight marks the end of care. Full article: https://belite.com/what-happens-after-stopping-wegovy-zepbound/ 2. How much muscle is lost on GLP-1 treatment? Most
Bottom line Survodutide, an investigational weekly dual glucagon/GLP-1 receptor agonist, produced significantly greater weight loss than placebo in the Phase 3 SYNCHRONIZE-1 trial. The evidence makes it a credible future obesity treatment, but it is not FDA approved, has no established place relative to Wegovy or Zepbound, and should not be purchased as an